Bionano Genomics (BNGO) EBIAT (2017 - 2025)
Historic EBIAT for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to -$8.5 million.
- Bionano Genomics' EBIAT rose 8078.24% to -$8.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$38.6 million, marking a year-over-year increase of 7158.19%. This contributed to the annual value of -$112.0 million for FY2024, which is 5181.92% up from last year.
- Per Bionano Genomics' latest filing, its EBIAT stood at -$8.5 million for Q3 2025, which was up 8078.24% from -$6.9 million recorded in Q2 2025.
- Bionano Genomics' EBIAT's 5-year high stood at -$3.1 million during Q1 2025, with a 5-year trough of -$112.6 million in Q3 2023.
- For the 5-year period, Bionano Genomics' EBIAT averaged around -$29.9 million, with its median value being -$30.0 million (2022).
- Per our database at Business Quant, Bionano Genomics' EBIAT plummeted by 25388.1% in 2023 and then skyrocketed by 9012.79% in 2025.
- Over the past 5 years, Bionano Genomics' EBIAT (Quarter) stood at -$22.9 million in 2021, then crashed by 68.53% to -$38.7 million in 2022, then decreased by 13.48% to -$43.9 million in 2023, then surged by 54.15% to -$20.1 million in 2024, then soared by 57.75% to -$8.5 million in 2025.
- Its EBIAT stands at -$8.5 million for Q3 2025, versus -$6.9 million for Q2 2025 and -$3.1 million for Q1 2025.